
Sino Biopharmaceutical
(OTC) SBMFF
Sino Biopharmaceutical Financials at a Glance
Market Cap
$11.29B
Revenue (TTM)
CN¥30.57B
Net Income (TTM)
CN¥3.87B
EPS (TTM)
$0.02
P/E Ratio
35.77
Dividend
$0.01
Beta (Volatility)
0.10 (Low)
Dividend
$0.01
Beta (Volatility)
0.10 (Low)
Price
$0.63
Volume
1,000
Open
$0.63
Price
$0.63
Volume
1,000
Open
$0.63
Previous Close
$0.63
Daily Range
$0.63 - $0.63
52-Week Range
$0.61 - $1.24
Estimated Earnings Date
Mar 26, 2026
Dividend
$0.01
Beta (Volatility)
0.10 (Low)
Price
$0.63
Volume
1,000
Open
$0.63
Previous Close
$0.63
Daily Range
$0.63 - $0.63
52-Week Range
$0.61 - $1.24
Estimated Earnings Date
Mar 26, 2026
SBMFF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Sino Biopharmaceutical
Industry
Pharmaceuticals
Sector
Health CareEmployees
21,435
CEO
S Y Tse
Website
www.sinobiopharm.comHeadquarters
Wan Chai, HK
SBMFF Financials
Key Financial Metrics (TTM)
Gross Margin
82%
Operating Margin
22%
Net Income Margin
7%
Return on Equity
7%
Return on Capital
14%
Return on Assets
3%
Earnings Yield
2.80%
Dividend Yield
1.82%
Payout Ratio
0.00%
Stock Overview
Market Cap
$11.29B
Shares Outstanding
17.84B
Volume
1.00K
Avg. Volume
192.844
Financials (TTM)
Gross Profit
CN¥25.45B
Operating Income
CN¥6.64B
EBITDA
CN¥7.79B
Operating Cash Flow
CN¥9.29B
Capital Expenditure
-CN¥1.70B
Free Cash Flow
CN¥7.59B
Cash & ST Invst.
CN¥22.56B
Total Debt
CN¥16.08B
Sino Biopharmaceutical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
CN¥8.79B
+10.7%
Gross Profit
CN¥7.25B
+11.2%
Gross Margin
82.47%
N/A
Market Cap
$11.29B
N/A
Market Cap/Employee
$463.19K
N/A
Employees
24,379
N/A
Net Income
CN¥1.69B
+12.3%
EBITDA
CN¥1.97B
-0.3%
Quarterly Fundamentals
Total Cash
CN¥22.96B
+57.3%
Total Debt
CN¥16.07B
+64.3%
Accounts Receivable
CN¥6.64B
+33.7%
Inventory
CN¥2.26B
-4.9%
Long Term Debt
CN¥7.65B
+267.8%
Short Term Debt
CN¥8.42B
+9.3%
Return on Assets
3.08%
N/A
Return on Invested Capital
13.69%
N/A
Free Cash Flow
CN¥1.44B
+8.2%
Operating Cash Flow
CN¥1.58B
+2.7%